There is huge potential market in Asia Pacific with its population reach to more than 4 billion. With rapid growth in recent years and an ageing population in China and India, the economy is booming and the healthcare industries in the Asia Pacific region will soon outpace long established markets in the West. We can infer from market development trends in China, India, Japan, Korea, Australia, and amongst the member states of the ASEAN economic community, that there are many significant opportunities and potential markets in the Asia Pacific.

　　The Japanese medical device industry stands out from all others. Japan is the world’s second largest medical device market after the USA with annual sales reaching USD $45 billion. Meanwhile, Indian medical software has gained a respectable reputation. However, due to such rapid development, the healthcare industry is facing many challenges. Incomplete our out of date regulation has restricted the pace of growth and has confused many pharmaceutical and medical device companies.

　　It is with this in mind that this summit is to be launched; gathering together established authorities to thoroughly interpret the latest policies, to analyze medical reforms and offer predictions of the upcoming schedule for reform. The Asia Pacific Healthcare Policy Summit will provide an effective platform for decision-makers to share their valuable experiences and express their opinions on dealing with the challenges and opportunities presented by medical reforms